SBIR-STTR Award

Deployable Pan-flavivirus and Pan-alphavirus Assays for Screening Pools of Medically Relevant Arthropod
Award last edited on: 9/30/2014

Sponsored Program
SBIR
Awarding Agency
DOD : Army
Total Award Amount
$812,818
Award Phase
2
Solicitation Topic Code
A10-158
Principal Investigator
Kirti I Dave

Company Information

VecTOR Test Systems Inc

3537 Old Conejo Road Unit 101
Newberry Park, CA 91320
   (805) 390-0647
   admin@vectortest.com
   www.vectortest.com
Location: Single
Congr. District: 26
County: Ventura

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2011
Phase I Amount
$119,984
VecTOR Test Systems, Inc will develop assays that can detect a broad range of alphaviruses and a broad range of flaviviruses in arthropod pools in a field setting. In Phase I, feasibility of the concept will be determined by developing a prototype assay(s) that has the potential to detect in a single multiplex format or as two group specific tests, at least three of the alphaviruses and at least two of the flaviviruses. The overall objective is to develop product/s that will quickly and accurately determine whether arthropods collected by preventive medicine units in the field are infected with medically relevant alphaviruses or flaviviruses in order to minimize the impact of the disease on operational capabilities. The technology is based on the simple and reliable immuno-chromatographic detection method by which sensitive test-strip based assays provide results in less than 30 minutes. The proposed assays will be easy to perform and results easy to interpret in far-forward situations. The assay will be made available in a kit with components required to perform the assay. The assay kit will be stable at ambient storage conditions.

Keywords:
Alphavirus, Flavivirus, Diagnostic Assay, Arbovirus, Entomology, Arthropod Vector, Infectious Disease

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
2011
Phase II Amount
$692,834
VecTOR Test Systems, Inc will develop assays that can detect a broad range of alphaviruses and a broad range of flaviviruses in arthropod pools in a field setting. In Phase I, feasibility of the concept was determined by successfully developing prototype assays that can detect in a single multiplex format and as two group specific tests various alphaviruses and flaviviruses. The overall objective is to develop product/s that will quickly and accurately determine whether arthropods collected by preventive medicine units in the field are infected with medically relevant alphaviruses or flaviviruses in order to minimize the impact of the disease on operational capabilities. In Phase II, research will continue to select and finalize reagents that will allow development of tests with required sensitivity and specificity. These tests will provide results in less than 30 minutes and be interpreted visually as well as with a battery operated reader for quantitative comparison and storing of results. The assays will be easy to perform and results easy to interpret in far-forward situations. The assay will be made available in a kit with components required to perform the assay. The assay kit will be developed rugged to withstand field storage conditions.

Keywords:
alphavirus, flavivirus, diagnostic assay, arbovirus, entomology, arthropod vector, infectious disease